Mark W. Cutler

6.3k citations
32 papers · 4.0k · 5 hit papers · h-index 18

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 detection and testing
    • Viral gastroenteritis research and epidemiology
  • Health top 2%
    • Vaccine Coverage and Hesitancy

Papers in

    • SARS-CoV-2 and COVID-19 Research 16
    • SARS-CoV-2 detection and testing 5
    • Viral gastroenteritis research and epidemiology 4
    • COVID-19 Clinical Research Studies 4
    • Bacterial Infections and Vaccines 6

Mark W. Cutler

30 papers receiving 3.9k citations

Mark W. Cutler's Hit Papers

Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine 2023 · 135 citations
1350+2+4Years since publication50010001.5k

Peers

Mark W. Cutler
Comparison fields: 5 of 132
  • Infectious Diseases 2.9k
  • Health 326
  • Animal Science and Zoology 435
  • Modeling and Simulation 152
  • Immunology 661
Replace Kristin R. Tompkins with:
Kristin R. Tompkins United States
Michele Paine McCullough United States
Marcelino Padilla United States
Renita Brown United States
Kaitlyn Cross United States
Cornelius Rohde Germany
Rhonda Pikaart-Tautges United States
Alexander Muik Germany
Etza Peters United States
Xuan He China
Mark W. Cutler relative to Kristin R. Tompkins United States Kristin R. Tompkins's profile →
Citations per field
00.5×1.5×
Kristin R. Tompkins · 1×
Citations per year

Countries citing papers authored by Mark W. Cutler

Since Specialization
Citations

This map shows the geographic impact of Mark W. Cutler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Cutler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Cutler more than expected).

Fields of papers citing papers by Mark W. Cutler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Cutler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Cutler. The network helps show where Mark W. Cutler may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark W. Cutler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark W. Cutler Line = papers co-authored together Mark W. Cutler links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#Work
1
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Hit paper breakdown →
20201512
2
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
Hit paper breakdown →
2021622
3
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Hit paper breakdown →
2021469
4
Neutralizing Activity of BNT162b2-Elicited Serum
Hit paper breakdown →
2021412
5 2021256
6
Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine
Hit paper breakdown →
2023135
7 202276
8 202169
9 202161
10 202260
11 202239
12 199837
13 202134
14 202334
15 202426
16 200422
17 198618
18 199218
19 201716
20 202014

About Mark W. Cutler

Mark W. Cutler is a scholar working on Infectious Diseases, Microbiology, Animal Science and Zoology, Epidemiology and Immunology, having authored 32 papers that have together received 4.0k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (16 papers), Animal Virus Infections Studies (7 papers), Pneumonia and Respiratory Infections (6 papers), Bacterial Infections and Vaccines (6 papers), SARS-CoV-2 detection and testing (5 papers), Viral gastroenteritis research and epidemiology (4 papers), COVID-19 Clinical Research Studies (4 papers) and Respiratory viral infections research (4 papers). The work is most often cited by research in Infectious Diseases (2.9k citations), Health (326 citations), Animal Science and Zoology (435 citations), Modeling and Simulation (152 citations) and Immunology (661 citations). Mark W. Cutler has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include David A. Cooper, Kena A. Swanson, Xuping Xie, Pei‐Yong Shi, Hongjie Xia, Philip R. Dormitzer, Scott C. Weaver, Jing Zou, Alexander Muik and Camila R. Fontes-Garfias. Their work appears in journals such as Vaccine, New England Journal of Medicine, Nature, Human Vaccines & Immunotherapeutics and The Pediatric Infectious Disease Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact